HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PFAS Disclosure, Supplier Contracts Can Help Shield Against Litigation – Dentons US Attorneys

Executive Summary

Cosmetics companies that disclose the presence of PFAS in their products and explain measures they are taking to minimize PFAS’ presence are better protected from lawsuits, says Dentons US attorney Michael Duvall.

You may also be interested in...



PFAS Remain High Priority For US FDA’s Cosmetics Office – Director Linda Katz

“We’ve been keeping tabs of the amount of products containing PFAS over the last several years and, unfortunately, we’re not seeing really a lot of it going away,” said Katz, director of the Office of Cosmetics and Colors, at the Independent Beauty Association’s Cosmetics Regulations Workshop.

California’s PFAS Ban In Cosmetics Limited To Intentionally Added Substances, Effective In 2025

Legislation awaiting the governor’s signature in California will ban the “forever chemicals” from cosmetics when intentionally added beginning in 2025, reflecting successful industry advocacy efforts.

Burt’s Bees Joins Beauty Brands In Court Over PFAS

Plaintiff Daniela Gruen says Burt’s Bees mascaras and lip shimmer are worthless or worth less than purchase price because the company failed to disclose that the products contain toxic and environmentally hazardous PFAS. She cites independent testing published last year by Mamavation in her complaint filed in California’s Northern District.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel